Learn about AI as an emerging and exciting tool to aid in diagnosing ocular disease as well as its capabilities to link disease prevention, treatment and patient outcomes. The conversation with Dr. Vas Sadda, Doheny’s President and Chief Scientific Officer, and Dr. Michael Ip, Director of the Doheny Image Reading Center will focus on the evolving role of AI in eye health.
Recent Posts
- Fall 2024 InSight Newsletter
- The Complement Factor H (Y402H) risk polymorphism for age-related macular degeneration affects metabolism and response to oxidative stress in the retinal pigment epithelium
- Three Doheny Doctors are LA Times’ Orange County Visionaries 2024
- Three Doheny Doctors are LA Times’ Orange County Visionaries 2024
- InSight at a Glance | October 2024